Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 10, 2011, Pages 2508-2515

  Perrone, Ronald D ^d   Abebe, Kaleab Z ^e   Schrier, Robert W ^b   Chapman, Arlene B ^c   Torres, Vicente E ^a   Bost, James ^e   Kaya, Diana ^e   Miskulin, Dana C ^d   Steinman, Theodore I ^h   Braun, William ^g   Winklhofer, Franz T ^f   Hogan, Marie C ^a   Rahbari Oskoui, Frederic ^c   Kelleher, Cass ^k   Masoumi, Amirali ^c   Glockner, James ^a   Halin, Neil J ^d   Martin, Diego ^c   Remer, Erick ^g   Patel, Nayana ^a   Pedrosa, Ivan ^h   Wetzel, Louis H ^f   Thompson, Paul A ^l   Miller, J Philip ⁱ   Meyers, Catherine M ^j   Bae, K Ty ^e   more..

^a Mayo Clinic   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TUFTS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

ⁱ WASHINGTON UNIVERSITY   (United States)

^j NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^k AMGEN INC   (United States)

^l SANFORD RESEARCH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALDOSTERONE; CREATININE; LISINOPRIL; POTASSIUM; SODIUM; TELMISARTAN;

ADULT; AGE; ALBUMINURIA; ALLOMETRY; ARTICLE; BLOOD PRESSURE REGULATION; BODY HEIGHT; BODY SURFACE; BODY WEIGHT; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL ASSESSMENT; CREATININE BLOOD LEVEL; DISEASE DURATION; DOUBLE BLIND PROCEDURE; EARLY INTERVENTION; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INTERVENTION STUDY; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; POTASSIUM URINE LEVEL; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINE LEVEL; URINE VOLUME;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 80053923405     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04610511     Document Type: Article

References (21)

1. Hateboer N, v Dijk M, Bogdanova N, Coto E, Saggar-Malik A, San Millan J, Torra R, Breuning M, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353(9147): 103-107, 1999
2. Schrier R: Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 20: 1888-1893, 2009
3. Perrone R, Ruthazer R, Terrin N: Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: Contribution of extrarenal complications to mortality. Am J Kidney Dis 38: 777-784, 2001
4. Fick G, Johnson A, Hammond W, Gabow P: Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5: 2048-2056, 1995
5. Ivy D, Shaffer E, Johnson A, Kimberling W, Dobin A, Gabow P: Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5: 2032-2036, 1995
6. Zeier M, Geberth S, Schmidt K, Mandelbaum A, Ritz E: Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3: 1451-1457, 1993
7. Chapman A, Johnson A, Rainguet S, Hossack K, Gabow P, Schrier R: Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 8: 1292-1297, 1997
8. Chapman A, Torres V, Perrone R, Steinman T, Bae K, Miller J, Miskulin D, Rahbari Oskoui F, Masoumi A, Hogan M, Winklhofer F, Braun W, Thompson P, Meyers C, Kelleher C, Schrier R: The HALT polycystic kidney disease trials: Design and implementation. Clin J Am Soc Nephrol 5: 102-109, 2010
9. Torres V, Chapman A, Perrone R, Bae K, Abebe K, Bost J, Miskulin D, Steinman T, Braun W, Winklhofer F, Hogan M, Oskoui F, Kelleher C, Masoumi A, Glockner J, Halin N, Martin D, Remer E, Patel N, Pedrosa I, Wetzel L, Thompson P, Miller J, Meyers C, Schrier R, HPS Group: The HALT Polycystic Kidney Disease Trials - Analysis of baseline parameters: Effect of gender and developmental programming in autosomal dominant polycystic kidney disease. Kidney Int, submitted, 2011
10. Fleiss J: The design and analysis of clinical experiments, New York, Wiley, 1999
11. Dubois D, Dubois E: A formula to estimate the approximate surface if height and weight are known. Arch Intern Med 17: 863-871, 1916
12. Brumback L, Kronmal R, Heckbert S, Ni H, Hundley W, Lima J, Bluemke D: Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. Int J Cardiovasc Imaging 26: 459-468, 2010
13. Salton C, Chuang M, O'Donnell C, Kupka M, Larson M, Kissinger K, Edelman R, Levy D, Manning W: Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol 39: 1055-1060, 2002
14. Sandstede J, Lipke C, Beer M, Hofmann S, Pabst T, Kenn W, Neubauer S, Hahn D: Age- and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 10: 438-442, 2000
15. Marcus J, DeWaal L, Götte M, van der Geest R, Heethaar R, Van Rossum A: MRI-derived left ventricular function parameters and mass in healthy young adults: Relation with gender and body size. Int J Card Imaging 15: 411-419, 1999
16. Schrier R, McFann K, Johnson A, Ecder T, Tison L: Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal dominant polycystic kidney disease: Results of a seven-year prospective randomized study. J Am Soc Nephrol 13: 1733-1739, 2002
17. Schrier R, McFann K, Johnson A: Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int 63: 678-685, 2003
18. Natori S, Lai S, Finn J, Gomes A, Hundley W, Jerosch-Herold M, Pearson G, Sinha S, Arai A, Lima J, Bluemke D: Cardiovascular function in multi-ethnic study of atherosclerosis: Normal values by age, sex, and ethnicity. AJR 186 [6 Suppl 2]: S357-S365, 2006
19. Cain P, Ahl R, Hedstrom E, Ugander M, Allansdotter-Johnsson A, Friberg P, Arheden H: Age and gender specific normal values of left ventricular mass, volume and function for gradient echo magnetic resonance imaging: A cross sectional study. BMC Med Imaging 9: 2, 2009
20. Alfakih K, Plein S, Thiele H, Jones T, Ridgway J, Sivananthan M: Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 17: 323-329, 2003
21. Lorenz C, Walker E, Morgan V, Klein S, Graham T Jr.: Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1: 7-21, 1999